Suchergebnisse - "Robert J Motzer"

PubPharm (11)

1

Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape

in: Genome Medicine | 2022

von Mahdi Golkaram | Fengshen Kuo | Sounak Gupta | +26

2

Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma

in: Journal for ImmunoTherapy of Cancer | 2022

von Jin Yao | Thomas Powles | David F McDermott | +11

3

Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) for Lenvatinib plus Everolimus Versus Everolimus Monotherapy in Patients with Advanced Renal Cell Carcinoma

in: European Urology Open Science | 2021

von Chung-Han Lee | Yin Wan | Alan Smith | +2

4

Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations

in: BMC Urology | 2020

von Yasser Ged | Ruby Gupta | Cihan Duzgol | +10

5

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial

in: Journal for ImmunoTherapy of Cancer | 2020

von Howard Gurney | Thomas Powles | Asim Amin | +25

6

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial

in: ESMO Open | 2020

von Howard Gurney | Thomas Powles | Laurence Albiges | +16

7

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)

in: Journal for ImmunoTherapy of Cancer | 2019

von Brian I. Rini | Dena Battle | Robert A. Figlin | +15

8

RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis

in: BMC Cancer | 2018

von Lin Yang | Anna Alyasova | Dingwei Ye | +3

9

Systemic Therapy for Metastatic Renal-Cell Carcinoma

enthalten in: The New England journal of medicine | 2017

von Dan L Longo | Toni K Choueiri | Robert J Motzer

10

Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets

in: Nature Communications | 2016

von Ying-Bei Chen | Jianing Xu | Anders Jacobsen Skanderup | +21